Primary amyloidosis patients with significant organ dysfunction tolerate autologous transplantation after conditioning with single-dose total body irradiation alone: A feasibility study

Biology of Blood and Marrow Transplantation

Volumn 9, Issue 6, 2003, Pages 397-404

  Blum, William ^a   Khoury, Hanna ^a   Lin, H S ^a   Vij, Ravi ^a   Goodnough, Lawrence T ^a   Devine, Steve ^a   DiPersio, John ^a   Adkins, Douglas ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloidosis; Autologous transplantation; Total body irradiation

Indexed keywords

ALPHA INTERFERON; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; HYPERTENSIVE FACTOR; MELPHALAN; PREDNISONE; STEROID; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; AMYLOIDOSIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CARDIOMYOPATHY; CARDIOTOXICITY; CAUSE OF DEATH; CHEMOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CONVALESCENCE; DISEASE COURSE; DRUG MEGADOSE; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; MALE; MORTALITY; MUCOSA INFLAMMATION; MULTIPLE ORGAN FAILURE; MYELODYSPLASIA; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PSYCHOSIS; RADIATION DOSE; REMISSION; RISK ASSESSMENT; STEM CELL MOBILIZATION; SURVIVAL RATE; THROMBOCYTOPENIA; WHOLE BODY RADIATION;

ADULT; AGED; AMYLOIDOSIS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARRHYTHMIA; CAUSE OF DEATH; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEASIBILITY STUDIES; FEMALE; HEART; HEART FAILURE, CONGESTIVE; HUMANS; LIFE TABLES; MALE; MIDDLE AGED; NEURAL TUBE DEFECTS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RADIATION DOSAGE; RADIATION INJURIES; REMISSION INDUCTION; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 1542577151     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(03)00106-X     Document Type: Article

References (20)

1. Kyle R.A. Gertz M.A. Greipp P.R. et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine [see comments] N Engl J Med. 336 1997 1202-1207
2. Dhodapkar M.V. Jagannath S. Vesole D. et al. Efficacy of pulse dexamethasone (DEX) plus maintenance alpha interferon (IFN) in primary systemic amyloidosis (AL) (abstract) Blood 86 1995 442A
3. Attal M. Harousseau J.L. Stoppa A.M. et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma N Engl J Med. 335 1996 91-97
4. Comenzo R.L. Vosburgh E. Falk R.H. et al. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients Blood 91 1998 3662-3670
5. Gertz M.A. Lacy M.Q. Gastineau D.A. et al. Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL) Bone Marrow Transplant. 26 2000 963-969
6. Comenzo R.L. Sanchorawala V. Fisher C. et al. Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis Br J Haematol. 104 1999 553-559
7. Saba N. Sutton D. Ross H. et al. High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant Bone Marrow Transplant. 24 1999 853-855
8. Gillmore J.D.Apperly J.F.Craddock C. et al. High dose melphalan and stem cell rescue for AL amyloidosis In Kyle R.A. Gertz M.A. (Eds.), Amyloid and amyloidosis 1999 102-104 Parthenon Publishing Pearl River, NY
9. Moreau P. Leblond V. Bourquelot P. et al. Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients Br J Haematol. 101 1998 766-769
10. Barlogie B. Jagannath S. Desikan K.R. et al. Total therapy with tandem transplants for newly diagnosed multiple myeloma Blood 93 1999 55-65
11. Comenzo R.L. Gertz M.A. Autologous stem cell transplantation for primary systemic amyloidosis Blood 99 2002 4276-4282
12. Blum W. Brown R. Lin H.-S. et al. Low dose (550cGy), single exposure total body irradiation and cyclophosphamide: consistent, durable engraftment of related donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity Biol Blood Marrow Transplant. 8 2002 608-612
13. Blade J. Samson D. Reece D. et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant Br J Haematol. 102 1998 1115-1123
14. Kaplan E.L. Meier P. Nonparametric estimation from incomplete observations J Am Stat Assoc. 53 1958 457-481
15. Dispenzieri A. Lacy M.Q. Kyle R.A. et al. Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival J Clin Oncol. 19 2001 3350-3356
16. Sanchorawala V. Wright D.G. Seldin D.C. et al. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis Bone Marrow Transplant. 28 2001 637-642
17. Sanchorawala V. Wright D. Seldin D. et al. High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial Blood 98 2001 [abstract 3389]
18. Pedersen-Bjergaard J. Andersen M.K. Christiansen D.H. Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation Blood 95 2000 3273-3279 [erratum appears in Blood 2000;96:1680]
19. Sevilla J. Rodriguez G. Hernandez-Maraver D. et al. Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation Ann Hematol. 8 2002 11-15
20. Metayer C. Curtis R. Vose J. Sobocinski K. Horowitz M. Bhatia S. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case control study Blood. 101 2003 2015-2023